1. Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid
    Gianfranco Baronzio et al, 2015, Front. Oncol. CrossRef
  2. Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy
    Vasiliki Gkretsi et al, 2015, Front. Oncol. CrossRef
  3. TRAIL, Wnt, Sonic Hedgehog, TGFβ, and miRNA Signalings Are Potential Targets for Oral Cancer Therapy
    Ammad Farooqi et al, 2017, IJMS CrossRef
  4. Role of transforming growth factor-β1 in triple negative breast cancer patients
    Mingxia Zhang et al, 2017, International Journal of Surgery CrossRef
  5. Physical oncology: New targets for nanomedicine
    Alba Nicolas-Boluda et al, 2018, Biomaterials CrossRef
  6. Collateral Damage Intended—Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy
    Ana Cavaco et al, 2017, IJMS CrossRef
  7. TGFβ pathway inhibition in the treatment of non-small cell lung cancer
    Pınar Ö. Eser et al, 2017, Pharmacology & Therapeutics CrossRef
  8. Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis
    Rola M. Saleeb et al, 2017, The American Journal of Surgical Pathology CrossRef
  9. Nanoparticle-based hyperthermia, a local treatment modulating the tumor extracellular matrix
    Jelena Kolosnjaj-Tabi et al, 2017, Pharmacological Research CrossRef
  10. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo
    Xi-Ran He et al, 2017, Journal of Ethnopharmacology CrossRef
  11. Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-β) signaling: an insight into Neuropilin-1 (NRP1) mediated tumorigenesis
    Sneha Vivekanandhan et al, 2018, Seminars in Cancer Biology CrossRef
  12. Solid Stress Facilitates Fibroblasts Activation to Promote Pancreatic Cancer Cell Migration
    Maria Kalli et al, 2018, Ann Biomed Eng CrossRef
  13. Adaptive immune cells are necessary for the enhanced therapeutic effect of sorafenib-loaded nanoparticles
    Zhi-Bin Zhao et al, 2018, Biomater. Sci. CrossRef
  14. Transforming growth factor-β modulates pancreatic cancer associated fibroblasts cell shape, stiffness and invasion
    Andreas Stylianou et al, 2018, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
  15. Stress alleviation strategy in cancer treatment: Insights from a mathematical model
    Fotios Mpekris et al, 2018, Z. Angew. Math. Mech. CrossRef
  16. A miRNA-145/TGF-β1 negative feedback loop regulates the cancer-associated fibroblast phenotype
    Genevieve E Melling et al, 2018 CrossRef
  17. Effects of platelets on cancer progression
    Léa Plantureux et al, 2018, Thrombosis Research CrossRef
  18. Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and Metastasis
    Vasiliki Gkretsi et al, 2018, Front. Oncol. CrossRef
  19. TGF-β1 induced fascin1 expression facilitates the migration and invasion of kidney carcinoma cells through ERK and JNK signaling pathways
    Jianyu Yang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  20. Peroxiredoxin 6 inhibits osteogenic differentiation and bone formation through human dental pulp stem cells and induces delayed bone development
    Kyung-Ran Park et al, 2018, Antioxidants & Redox Signaling CrossRef
  21. Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy
    Fotios Mpekris et al, 2017, Journal of Controlled Release CrossRef
  22. Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis
    Yajuan Zhang et al, 2018, Molecular Cell CrossRef
  23. Unveiling gene trait relationship by cross-platform meta-analysis on Chinese hamster ovary cell transcriptome
    Liang Zhao et al, 2017, Biotechnol. Bioeng. CrossRef
  24. Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
    Rasmus Siersbæk et al, 2018, Genes Dev. CrossRef
  25. Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity
    John D. Martin et al, 2016, Cold Spring Harb Perspect Med CrossRef
  26. Transforming growth factor β1-induced collagen production in myofibroblasts is mediated by reactive oxygen species derived from NADPH oxidase 4
    Yuma Hotta et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  27. Novel Transforming Growth Factor-Beta Receptor 1 Antagonists through a Pharmacophore-Based Virtual Screening Approach
    Junhao Jiang et al, 2018, Molecules CrossRef
  28. The Solid Mechanics of Cancer and Strategies for Improved Therapy.
    Triantafyllos Stylianopoulos, 0 CrossRef
  29. Obstacles to T cell migration in the tumor microenvironment
    Alba Nicolas-Boluda et al, 2018, Comparative Immunology, Microbiology and Infectious Diseases CrossRef
  30. A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue
    Helga Bergholtz et al, 2019, J Mammary Gland Biol Neoplasia CrossRef
  31. TGF-β in Pancreatic Disease: Mechanisms and Therapeutic Potential
    Qi Zhou et al, 2019, Pharmacological Research CrossRef
  32. Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis
    Guy A Conlon et al, 2019, J. Pathol. CrossRef
  33. null
    Irina Negut et al, 2019 CrossRef
  34. Dianthus superbus Improves Glomerular Fibrosis and Renal Dysfunction in Diabetic Nephropathy Model
    Jung Yoon et al, 2019, Nutrients CrossRef
  35. Searching for the link; mechanisms underlying liver regeneration and recurrence of colorectal liver metastasis post partial hepatectomy
    Georgina E. Riddiough et al, 2019, Journal of Gastroenterology and Hepatology CrossRef
  36. TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer
    Christina Schug et al, 2019 CrossRef
  37. Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis.
    Hsiao-Chen Chiu et al, 2019, J Clin Med CrossRef
  38. Anti-Müllerian Hormone Expression in Endometrial Cancer Tissue
    Marek Gowkielewicz et al, 2019, IJMS CrossRef
  39. Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models
    Heng Sheng Sow et al, 2019, Cells CrossRef
  40. Cancer-associated fibroblasts enact field cancerization by promoting extratumoral oxidative stress
    Jeremy Soon Kiat Chan et al, 2017, Cell Death Dis CrossRef
  41. Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner
    Panagiotis Papageorgis et al, 2017, Sci Rep CrossRef
  42. Collagen content and extracellular matrix cause cytoskeletal remodelling in pancreatic fibroblasts
    Andreas Stylianou et al, 2019, J. R. Soc. Interface CrossRef
  43. Bone Metastasis Phenotype and Growth Undergo Regulation by Micro-Environment Stimuli: Efficacy of Early Therapy with HGF or TGFβ1-Type I Receptor Blockade
    Paola Bendinelli et al, 2019, IJMS CrossRef
  44. null
    Jonathan E. Schoenhals et al, 2016 CrossRef
  45. Chimeric antigen receptors designed to overcome transforming growth factor-β-mediated repression in the adoptive T-cell therapy of solid tumors
    Jordan Hartley et al, 2019, Clin Transl Immunol CrossRef
  46. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia
    Joanna D.C.C. Lima et al, 2019, Journal of Cachexia, Sarcopenia and Muscle CrossRef
  47. Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells
    Rola M. Saleeb et al, 2019, The American Journal of Pathology CrossRef
  48. Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells
    Sreeharsha Gurrapu et al, 2019, Sci. Signal. CrossRef
  49. Role of the Microenvironment in Regulating Normal and Cancer Stem Cell Activity: Implications for Breast Cancer Progression and Therapy Response
    Vasudeva Bhat et al, 2019, Cancers CrossRef
  50. New insights into the functions of intersectin-1s
    Sanda Predescu et al, 2015, Communicative & Integrative Biology CrossRef
  51. Discovery of New Inhibitors of Transforming Growth Factor-Beta Type 1 Receptor by Utilizing Docking and Structure-Activity Relationship Analysis
    null Jiang et al, 2019, IJMS CrossRef
  52. ATP-binding cassette sub-family C member 4 (ABCC4) is overexpressed in human NK/T-cell lymphoma and regulates chemotherapy sensitivity: Potential as a functional therapeutic target
    Xudong Zhang et al, 2015, Leukemia Research CrossRef
  53. Remodeling of extracellular matrix due to solid stress accumulation during tumor growth
    Athanassios P. Pirentis et al, 2015, Connective Tissue Research CrossRef
  54. Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer
    Ketan Patel et al, 2016, Nanomedicine CrossRef
  55. Profile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: Regulation by IL-1α and TGFβ and Implications for Migration of Pancreatic Cancer Cells
    Vegard Tjomsland et al, 2016, Neoplasia CrossRef
  56. TGF-ß alterations in oral squamous cell carcinoma. Narrative review
    Jorge Candia, 2016, J Oral Res CrossRef
  57. Hyaluronan-Derived Swelling of Solid Tumors, the Contribution of Collagen and Cancer Cells, and Implications for Cancer Therapy
    Chrysovalantis Voutouri et al, 2016, Neoplasia CrossRef
  58. EMT and inflammation: inseparable actors of cancer progression.
    Meggy Suarez-Carmona et al, 2017, Mol Oncol CrossRef
  59. Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment
    Lakisha D. Moore-Smith et al, 2017, Sci Rep CrossRef
  60. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway
    Jong Hyun Lee et al, 2019, Pharmacological Research CrossRef
  61. Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β
    Alessandra Metelli et al, 2020, Sci. Transl. Med. CrossRef
  62. Size-Tunable Strategies for a Tumor Targeted Drug Delivery System
    Wenqi Yu et al, 2020, ACS Cent. Sci. CrossRef
  63. TGF-beta: a master immune regulator
    Christopher Larson et al, 2020, Expert Opinion on Therapeutic Targets CrossRef
  64. Mechanisms of TGFβ3 Action as a Therapeutic Agent for Promoting the Synthesis of Extracellular Matrix Proteins in Hyaline Cartilage
    M. S. Bozhokin et al, 2020, Biochemistry Moscow CrossRef
  65. Development of tissue factor-targeted liposomes for effective drug delivery to stroma-rich tumors
    Kosuke Shimizu et al, 2020, Journal of Controlled Release CrossRef
  66. Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention
    Juana Martín-López et al, 2018, Oncotarget CrossRef
  67. Targeting hyaluronan accumulation in the tumor microenvironment
    Xiaoming Li et al, 2018, Oncotarget CrossRef
  68. Pirfenidone normalizes the tumor microenvironment to improve chemotherapy
    Christiana Polydorou et al, 2017, Oncotarget CrossRef
  69. STIM1 plays an important role in TGF-β-induced suppression of breast cancer cell proliferation
    Huanyi Cheng et al, 2016, Oncotarget CrossRef
  70. Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathway
    Amber A. Bokhari et al, 2016, Oncotarget CrossRef
  71. Novel Medicinal Mushroom Blend as a Promising Supplement in Integrative Oncology: A Multi-Tiered Study using 4T1 Triple-Negative Mouse Breast Cancer Model
    Elisa Roda et al, 2020, IJMS CrossRef
  72. “High Treg” Inflammations Promote (Most) Non-Hematologic Cancers While “Low Treg” Inflammations Promote Lymphoid Cancers

    Zeev Elkoshi, 2020, JIR CrossRef
  73. The Role of Tumor-Associated Myeloid Cells in Modulating Cancer Therapy
    Christiana M. Neophytou et al, 2020, Front. Oncol. CrossRef
  74. Clinical and genomic landscape of hepatocellular carcinoma subtypes with various proportions of nonleukocyte stromal cells
    Jie Peng et al, 2020, Gene CrossRef
  75. Co-inhibition of the TGF-β pathway and the PD-L1 checkpoint by pH-responsive clustered nanoparticles for pancreatic cancer microenvironment regulation and anti-tumor immunotherapy
    Yang Wang et al, 2020, Biomater. Sci. CrossRef
  76. Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling
    Yi-Jun Qi et al, 2020, PLoS Biol CrossRef
  77. The Tumor Suppressor TGFBR3 Blocks Lymph Node Metastasis in Head and Neck Cancer
    Wei-Yu Fang et al, 2020, Cancers CrossRef
  78. The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A Review.
    Matthias Pinter et al, 2021, JAMA Oncol CrossRef
  79. Angiotensin Inhibition, TGF-β and EMT in Cancer.
    Fabian Bernhard Pallasch et al, 2020, Cancers (Basel) CrossRef
  80. Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility
    Amanpreet Kaur et al, 2019, Cancer Discov CrossRef
  81. Something Old, Something New: The Tumor Microenvironment Comes of Age
    Kerrie L. Marie et al, 2019, Cancer Discov CrossRef
  82. Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formyl-Peptide Receptors.
    Nunzia Novizio et al, 2020, Cells CrossRef
  83. Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell–Mediated Sodium Iodide Symporter (NIS) Gene 131I Therapy
    Christina Schug et al, 2019, Clin Cancer Res CrossRef
  84. Myeloid Cell–Derived TGFβ Signaling Regulates ECM Deposition in Mammary Carcinoma via Adenosine-Dependent Mechanisms
    Georgii Vasiukov et al, 2020, Cancer Res CrossRef
  85. Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer
    Qianghua Hu et al, 2017, Clin Cancer Res CrossRef
  86. Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives
    Daniel M. Girardi et al, 2020, Pharmaceuticals CrossRef
  87. Prognostic significance of transforming growth factor β receptor II in clinical stage III breast cancer patients - a pilot study
    Sherif Refaat et al, 2021, BD CrossRef
  88. TGFβ signaling networks in ovarian cancer progression and plasticity
    Asha Kumari et al, 2021, Clin Exp Metastasis CrossRef
  89. The Tumor Microenvironment Impairs Th1 IFNγ Secretion through Alternative Splicing Modifications of Irf1 Pre-mRNA
    Antoine Bernard et al, 2021, Cancer Immunol Res CrossRef
  90. null
    Raziye Piranlioglu et al, 2021 CrossRef
  91. Cancer-associated cells release citrate to support tumour metastatic progression
    Konstantin Drexler et al, 2021, Life Sci. Alliance CrossRef
  92. Characterization of the Immune Cell Infiltration Profile in Pancreatic Carcinoma to Aid in Immunotherapy
    De Luo et al, 2021, Front. Oncol. CrossRef
  93. Self-driving armored CAR-T cells overcome a suppressive milieu and eradicate CD19+ Raji lymphoma in preclinical models
    Brian Webster et al, 2021, Molecular Therapy CrossRef
  94. Gene Expression Analysis Provides New Insights into the Mechanism of Intramuscular Fat Formation in Japanese Black Cattle
    Shuji Ueda et al, 2021, Genes CrossRef
  95. Pancreatic Adenocarcinoma Therapeutics Targeting RTK and TGF Beta Receptor
    Hsin-Han Yang et al, 2021, IJMS CrossRef
  96. Blood levels of growth and progression factors in patients with locally advanced breast cancer during neoadjuvant chemotherapy
    E. M. Frantsiyants et al, 2021, jour CrossRef
  97. Optimization strategies for expression of a novel bifunctional anti-PD-L1/TGFBR2-ECD fusion protein
    Zhang-zhao Gao et al, 2022, Protein Expression and Purification CrossRef
  98. ANXA1 Contained in EVs Regulates Macrophage Polarization in Tumor Microenvironment and Promotes Pancreatic Cancer Progression and Metastasis
    Nunzia Novizio et al, 2021, IJMS CrossRef
  99. Impact of a Desmoplastic Tumor Microenvironment for Colon Cancer Drug Sensitivity: A Study with 3D Chimeric Tumor Spheroids
    Venkanagouda S. Goudar et al, 2021, ACS Appl. Mater. Interfaces CrossRef
  100. null
    Jasmeet Kaur Virdi et al, 2021 CrossRef
  101. Stromal disruption facilitating invasion of a ‘nano-arsenal’ into the solid tumor
    Yige Fu et al, 2021, Drug Discovery Today CrossRef
  102. TGF-β1 and its signal molecules: are they correlated with the elasticity characteristics of breast lesions?
    Meng Ke Zhang et al, 2021, BMC Cancer CrossRef
  103. Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment.
    Karam Soliman, 0 CrossRef
  104. Association of SMAD7 genetic markers and haplotypes with colorectal cancer risk
    Maryam Alidoust et al, 2022, BMC Med Genomics CrossRef
  105. Inflammation and Myeloid Cells in Cancer Progression and Metastasis
    Jenying Deng et al, 2022, Front. Cell Dev. Biol. CrossRef
  106. Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment
    Xiwei Wang et al, 2022, J Immunother Cancer CrossRef
  107. Tumor microenvironment-responsive size-switchable drug delivery nanosystems
    Yue Hu et al, 2022, Expert Opinion on Drug Delivery CrossRef
  108. Synergistic checkpoint-blockade and radiotherapy–radiodynamic therapy via an immunomodulatory nanoscale metal–organic framework
    Kaiyuan Ni et al, 2022, Nat Biomed Eng CrossRef
  109. Polymeric Systems for Cancer Immunotherapy: A Review
    Thai Minh Duy Le et al, 2022, Front. Immunol. CrossRef
  110. Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers
    William L. Harryman et al, 2022, Front. Cell Dev. Biol. CrossRef
  111. Modeling the Mechanical Stiffness of Pancreatic Ductal Adenocarcinoma
    Delanyo Kpeglo et al, 2022, Matrix Biology Plus CrossRef
  112. The solid tumor microenvironment—Breaking the barrier for T cells
    Hasan Simsek et al, 2022, BioEssays CrossRef
  113. Targeting the Tumor Biophysical Microenvironment to Reduce Resistance to Immunotherapy
    Tian Zhang et al, 2022, Advanced Drug Delivery Reviews CrossRef
  114. TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation
    Bikash Chandra Jena et al, 2022, Experimental Cell Research CrossRef
  115. Targeting Soluble Factors Involved in Inflammatory Cancer Microenvironment
    M. Gayathri et al, 2022, Curr Pharmacol Rep CrossRef
  116. Shaping the “hot” immunogenic tumor microenvironment by nanoparticles co‐delivering oncolytic peptide and TGF ‐β1 siRNA for boosting checkpoint blockade therapy
    Cao Dai Phung et al, 2022, Bioengineering & Transla Med CrossRef
  117. Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics
    Rita Balsano et al, 2022, Cells CrossRef
  118. TGF-β1 upregulates Sar1a expression and induces procollagen-I secretion in hypertrophic scarring fibroblasts
    Keun Jae Ahn et al, 2022 CrossRef
  119. A novel cell-based assay for the high-throughput screening of epithelial–mesenchymal transition inhibitors: Identification of approved and investigational drugs that inhibit epithelial–mesenchymal transition
    Hiroyuki Ishikawa et al, 2022, Lung Cancer CrossRef
  120. Dickkopf-3: An Update on a Potential Regulator of the Tumor Microenvironment
    Zainab Al Shareef et al, 2022, Cancers CrossRef
  121. Mechanism of Extracellular Vesicle Secretion Associated with TGF-β-Dependent Inflammatory Response in the Tumor Microenvironment
    Klaudia Bonowicz et al, 2022, IJMS CrossRef